Venture Life Group plc (AIM:VLG)

Market Cap	81.02M +16.1%
Revenue (ttm)	35.17M +264.0%
Net Income	6.13M +725.5%
EPS	0.05 +782.5%
Shares Out	121.83M
PE Ratio	13.23
Forward PE	16.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,002
Open	66.50
Previous Close	66.50
Day's Range	66.50 - 66.50
52-Week Range	52.00 - 72.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About Venture Life Group

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms rela...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: VLG

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error